Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning? - PubMed (original) (raw)
Editorial
. 2012 Mar 20;30(9):898-901.
doi: 10.1200/JCO.2011.38.5492. Epub 2012 Feb 13.
- PMID: 22331930
- DOI: 10.1200/JCO.2011.38.5492
Editorial
Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning?
Hope S Rugo. J Clin Oncol. 2012.
No abstract available
Comment on
- First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
Bergh J, Bondarenko IM, Lichinitser MR, Liljegren A, Greil R, Voytko NL, Makhson AN, Cortes J, Lortholary A, Bischoff J, Chan A, Delaloge S, Huang X, Kern KA, Giorgetti C. Bergh J, et al. J Clin Oncol. 2012 Mar 20;30(9):921-9. doi: 10.1200/JCO.2011.35.7376. Epub 2012 Feb 13. J Clin Oncol. 2012. PMID: 22331954 Clinical Trial.
Similar articles
- Upfront adjuvant aromatase inhibitors in women with lobular breast cancer.
Montemurro F. Montemurro F. Eur J Cancer. 2013 Oct;49(15):3376-7. doi: 10.1016/j.ejca.2013.06.028. Epub 2013 Jul 15. Eur J Cancer. 2013. PMID: 23867125 No abstract available. - Different adjuvant chemotherapy regimens in older breast cancer patients?
Wildiers H, Brain E. Wildiers H, et al. Ann Oncol. 2015 Apr;26(4):613-615. doi: 10.1093/annonc/mdv015. Epub 2015 Jan 18. Ann Oncol. 2015. PMID: 25600566 No abstract available. - Letter to the editor - author's response.
van de Water W, Fontein DB, van de Velde CJ. van de Water W, et al. Eur J Cancer. 2013 Oct;49(15):3378-9. doi: 10.1016/j.ejca.2013.06.029. Epub 2013 Jul 24. Eur J Cancer. 2013. PMID: 23890770 No abstract available. - Infiltrating lobular carcinoma of the breast: systemic treatment.
Farese SA, Aebi S. Farese SA, et al. Breast Dis. 2008-2009;30:45-52. doi: 10.3233/BD-2009-0281. Breast Dis. 2008. PMID: 19850995 Review. - Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.
Di Vita M, Zanghì A, Lanzafame S, Cavallaro A, Piccolo G, Berretta M, Grosso G, Cappellani A. Di Vita M, et al. Clin Ter. 2011;162(5):451-6. Clin Ter. 2011. PMID: 22041804 Review.
Cited by
- The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer.
Yin C, Ma G, Rong Y, Kong P, Yang Q, Jiang C, Liao F, Zhang B, He W, Xia L. Yin C, et al. J Cancer. 2016 Sep 13;7(13):1901-1906. doi: 10.7150/jca.15802. eCollection 2016. J Cancer. 2016. PMID: 27698931 Free PMC article. - Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
Yadav K, Lim J, Choo J, Ow SGW, Wong A, Lee M, Chan CW, Hartman M, Lim SE, Ngoi N, Tang SW, Ang Y, Chan G, Chong WQ, Tan HL, Tan SH, Goh BC, Lee SC. Yadav K, et al. Breast Cancer Res Treat. 2022 Feb;192(1):131-142. doi: 10.1007/s10549-021-06470-7. Epub 2021 Dec 20. Breast Cancer Res Treat. 2022. PMID: 34928481 Free PMC article. Clinical Trial. - Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.
Argyros O, Karampelas T, Varela A, Asvos X, Papakyriakou A, Agalou A, Beis D, Davos CH, Fokas D, Tamvakopoulos C. Argyros O, et al. Oncotarget. 2017 Jun 6;8(23):37250-37262. doi: 10.18632/oncotarget.16763. Oncotarget. 2017. PMID: 28422745 Free PMC article. - Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.
Vasudev NS, Reynolds AR. Vasudev NS, et al. Angiogenesis. 2014 Jul;17(3):471-94. doi: 10.1007/s10456-014-9420-y. Epub 2014 Jan 31. Angiogenesis. 2014. PMID: 24482243 Free PMC article. Review. - Emerging targeted agents in metastatic breast cancer.
Zardavas D, Baselga J, Piccart M. Zardavas D, et al. Nat Rev Clin Oncol. 2013 Apr;10(4):191-210. doi: 10.1038/nrclinonc.2013.29. Epub 2013 Mar 5. Nat Rev Clin Oncol. 2013. PMID: 23459626 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical